Managing Patients with Cutaneous B-Cell and T-Cell Lymphomas Other Than Mycosis Fungoides.

about

Systemic therapy for cutaneous T-cell lymphoma: who, when, what, and why?

P2860

Q30239965-822F43D7-33D7-4071-838D-19B5D3EFD5ED

P2860

Managing Patients with Cutaneous B-Cell and T-Cell Lymphomas Other Than Mycosis Fungoides.

Item

http://www.wikidata.org/entity/Q38813983

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Managing Patients with Cutaneo ...... Other Than Mycosis Fungoides.

@en

type

Item

label

Managing Patients with Cutaneo ...... Other Than Mycosis Fungoides.

@en

prefLabel

Managing Patients with Cutaneo ...... Other Than Mycosis Fungoides.

@en

P1476

Managing Patients with Cutaneo ...... Other Than Mycosis Fungoides.

@en

P2093

Alison Moskowitz

http://www.w3.org/2001/XMLSchema#string

Meenal Kheterpal

http://www.w3.org/2001/XMLSchema#string

Neha Mehta-Shah

http://www.w3.org/2001/XMLSchema#string

Patricia L Myskowski

http://www.w3.org/2001/XMLSchema#string

Pooja Virmani

http://www.w3.org/2001/XMLSchema#string

Steven M Horwitz

http://www.w3.org/2001/XMLSchema#string

P2860

EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma

Molecular cytogenetic analysis of chromosomal breakpoints in the IGH, MYC, BCL6, and MALT1 gene loci in primary cutaneous B-cell lymphomas

Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment.

Primary cutaneous follicle center cell lymphoma with follicular growth pattern.

Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphoma.

New and experimental skin-directed therapies for cutaneous lymphomas.

Cyclosporine A as a Primary Treatment for Panniculitis-like T Cell Lymphoma: A Case with a Long-Term Remission.

ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes.

WHO-EORTC classification for cutaneous lymphomas.

Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group study 0014.

P2888

s11899-016-0322-5

P304

224-233

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11899-016-0322-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1030070092

http://www.w3.org/2001/XMLSchema#string

P698

27101016

http://www.w3.org/2001/XMLSchema#string

P932

5611851

http://www.w3.org/2001/XMLSchema#string

Managing Patients with Cutaneous B-Cell and T-Cell Lymphomas Other Than Mycosis Fungoides.

about

P2860

P2860

Managing Patients with Cutaneous B-Cell and T-Cell Lymphomas Other Than Mycosis Fungoides.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P932